GranuFlo and NaturaLyte Recall
In March 2012, the Food and Drug Administration (FDA) issued a recall of all GranuFlo and NaturaLyte products based on potentially fatal side effect warnings cited in a memo from the manufacturer Fresenius Medical Care (FMC).
The memo included evidence that high bicarbonate levels caused by GranuFlo and NaturaLyte can increase the risk of heart attack, stroke, cardiac arrest and death among hemodialysis patients. Fresenius Medical Care sent the initial internal memo only to FMC owned dialysis centers and failed to issue the same warning to the thousands of dialysis clinics not owned by FMC.
Fresenius Medical Care treats more than one third of the estimated 400,000 Americans currently receiving dialysis treatments. They are a leading supplier of dialysis machines and disposable products.
If you or a loved one experienced GranuFlo or NaturaLyte side effects such as heart attack, stroke or metabolic alkalosis after receiving dialysis treatment, contact the lawyers at Hissey Kientz, LLP for a free case evaluation. You can reach us by calling toll-free at 1-866-275-4454, or by filling out our free contact form on the right of this page.